Adding Cancer Vaccine to Avelumab Doesn’t Boost PFS in Gynecologic Cancer
The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.
The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.
This cohort study examines whether there is an association of diet quality and dietary inflammatory potential with prostate cancer grade reclassification in men with grade…
The former President has been fighting to win back his wealthiest donors, while actively courting new ones—what do they expect to get in return?
Ancillary testing is essential for the fine-needle aspiration interpretation of lymphoproliferative neoplasms. This review focuses on ancillary tests that are essential to accurate fine-needle aspira…
Exposure to particulate matter consisting of fine particles less than or equal to 2.5 microns in diameter was significantly associated with worse overall survival in…
Chairs : Hermann Einsele, Maria Theresa Krauth, Maria Victoria Mateos, Omar Nadeem April 3-5, 2025 – Vienna, Austria Chairs: Hermann Einsele, Maria Theresa Krauth, Maria-Victoria…
Use of pembrolizumab with neoadjuvant chemotherapy and as monotherapy in the adjuvant setting extended OS for patients with early-stage triple-negative breast cancer, according to results…
During a Case-Based Roundtable® event, Bradley McGregor, MD, moderated a discussion on prognosis and treatment approaches for a patient with stage IV papillary renal cell carcinoma.
We summarize the final comparative analysis results from the phase III ALPINE trial of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL published in Blood…
PURPOSEPrevious studies suggest that external-beam partial breast irradiation (PBI) delivered twice a day can lead to increased adverse cosmesis (AC). The objective of our trial…